• Icahn pissed, writes letter to Amylin demanding Chairman Joseph Cook resign. Given the recent Novo debacle with lira, Byetta issues and the possible impending backlash with LAR from FDA (i.e. thyroid), I would have left A LONG TIME AGO. [Bloomberg]

• Genentech execs are bailing on Roche; lower employees not so lucky – they may get axe. [WSJ]

• Just days after announcing its CEO would take a pay cut and that it would default on a $7M debt obligation, CRO PharmEng has filed for bankruptcy. [The Star]

• Sirion Therapeutics is announcing positive results from an interim analysis of its Phase 2 fenretinide trial for geographic atrophy (GA) associated with age-related macular degeneration. [Pharmalive]

• India’s Wockhardt still looking for love, partner, something… [SCRIP]

• Something we already knew: oncologists don’t like giving patients pills, more money in infusions! [New York Times]

• Finally, Merck blames pharma industry’s problems on researchers – says scientists don’t discover enough drugs. WTF? Do you know how f-ing hard it is to discover something that 1. works, 2. is safe, 3. is needed , 4. is scalable, 5. will garner exec and investor interest, 6. will sell, 7. will be developed correctly, 8. can get patented, 9. etc, etc, etc the list goes on and on and on. Unbelievable. [ScienceMag]

Image from msn

Related Posts

No related posts.